Table 2. Characteristics of the colistin-resistant Klebsiella pneumoniae and Enterobacter spp. clinical isolates, France, January–December 2014 (n = 43) .
Isolate | Site of isolation |
Origin | MIC CSa | mgrB genotype | Carbapenemase | Associated beta-lactamase | Co-resistancesb | ST | PFGE |
---|---|---|---|---|---|---|---|---|---|
1 | ? | Picardie | 32 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT | 11 | A |
2 | Catheter | Picardie | 8 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
3 | Rectal swab | Picardie | 4 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
4 | Rectal swab | Picardie | 4 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
5 | Rectal swab | Picardie | 64 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
6 | Urine | Picardie | 32 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
7 | Rectal swab | Picardie | 64 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
8 | Wound | Picardie | 4 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
9 | Respiratory | Picardie | 4 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
10 | Rectal swab | Picardie | 4 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
11 | Rectal swab | Picardie | 8 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
12 | Rectal swab | Picardie | 64 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
13 | Rectal swab | Picardie | 8 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
14 | Rectal swab | Picardie | 4 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
15 | Rectal swab | Picardie | 4 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 11 | A |
16 | Rectal swab | Nord-Pas-de-Calais | 128 | IS1R in promoter region (between nt −45 and −46) | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 147 | B |
17 | Rectal swab | Ile-de-France | 128 | mgrB WT | NDM | CTX-M-15 | CIP GM SXT TIG | 147 | C |
18 | Rectal swab | PACA | >128 | ISKpn26-like in coding region (between nt +74 and +75) | KPC | - | CIP AK SXT TIG | 258 | D |
19 | Rectal swab | Rhône-Alpes | 128 | MgrB truncated (27 amino acids) | KPC | - | CIP AK SXT TIG | 258 | E |
20 | Blood | PACA | 16 | Full gene deletionc | KPC | - | CIP AK SXT TIG | 258 | F |
21 | Rectal swab | Lorraine | 64 | Single nucleotide deletion (nt 74) | OXA-48 | CTX-M-15 | CIP GM | 101 | G |
22 | Rectal swab | Ile-de-France | 32 | Single nucleotide deletion (nt 23) | OXA-48 | CTX-M-15 | CIP GM | 101 | H |
23 | Rectal swab | Ile-de-France | 64 | IS1R in promoter region (between nt −36 and −37) | OXA-48 + NDM | CTX-M-15 | CIP GM | 101 | I |
24 | Urine | PACA | 64 | IS1R in promoter region (between nt −45 and −46) | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 101 | J |
25 | Abcess | Ile-de-France | 32 | MgrB M27K | OXA-48 | CTX-M-15 | CIP GM | 101 | K |
26 | Urine | Pays de la Loire | 128 | Duplication of 19 nucleotides | OXA-48 | CTX-M-15 | CIP SXT FOS | 101 | L |
27 | Urine | PACA | 64 | IS1R in coding region (between nt +21 and +22) | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 307 | M |
28 | Rectal swab | PACA | 64 | mgrB WT | OXA-48 | CTX-M-15 | CIP GM SXT TIG FOS | 307 | M |
29 | Rectal swab | PACA | 64 | IS5-like in coding region (between nt +74 and +75) | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 307 | M |
30 | Urine | PACA | >128 | Full gene deletionb | OXA-48 | - | CIP GM AK SXT TIG FOS | 611 | N |
31 | Rectal swab | Ile-de-France | 32 | ISKpn14-like in promoter region (between nt −45 and −46) | OXA-48 | - | CIP GM SXT TIG | 23 | O |
32 | Rectal swab | PACA | 32 | IS102-like in coding region (between nt +36 and +37) | OXA-48 | CTX-M-15 | CIP GM SXT TIG | 20 | P |
33 | Respiratory | Ile-de-France | 32 | IS1R in promoter region (between nt −61 and −62) | OXA-48 | CTX-M-15 | CIP SXT TIG FOS | Q | |
34 | Blood | PACA | >128 | mgrB WT | OXA-48 | CTX-M-15 | CIP SXT TIG | 39 | R |
35 | Rectal swab | PACA | 32 | MgrB truncated (32 amino acids) | OXA-48 | - | FOS | 13 | S |
36 | Rectal swab | Nord-Pas-de-Calais | 64 | mgrB WT | OXA-48 + VIM | CTX-M-15 | CIP GM SXT | NA | T |
37 | Stools | Languedoc-Roussillon | 64 | mgrB WT | OXA-48 | CTX-M-15 | GM AK | NA | U |
38 | Respiratory | Ile-de-France | 32 | mgrB WT | VIM | - | SXT TIG | NA | V |
39 | Rectal swab | PACA | >128 | mgrB WT | OXA-48 | - | CIP GM SXT TIG | NA | W |
40 | Rectal swab | Ile-de-France | 16 | mgrB WT | OXA-48 | - | FOS | NA | X |
41 | Rectal swab | PACA | >128 | mgrB WT | IMP | CTX-M-2 | No | NA | Y |
42 | Respiratory | Rhône-Alpes | >128 | mgrB WT | OXA-48 | - | TIG | NA | Z |
43 | Urine | Nord-Pas-de-Calais | >128 | mgrB WT | VIM-1 | - | CIP TIG | NA | α |
Isolates 1-35: Klebsiella pneumoniae; 36–42: Enterobacter cloacae; 43: Enterobacter asburiae.
AK: amikacin; CIP: ciprofloxacin; CS: colistin; FOS: fosfomycin; GM: gentamicin; MIC: minimum inhibitory concentration; NA: not applicable; nt: nucleotide; PACA: Provence-Alpes-Côte-d’Azur; PFGE: pulsed-field gel electrophoresis; ST: sequence type; SXT: trimethoprim-sulfamethoxazole; TIG: tigecycline; WT: wildtype.
a MIC of colistin determined by broth microdilution method.
b Resistant or intermediate susceptibility to antibiotic.
c Full gene deletion: no PCR product was detected with external or internal primers.